Clinical Trial

Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT

Recruiting
View on ClinicalTrials.gov →
Summary
Head and neck cancer (HNC) patients undergoing concurrent chemoradiotherapy (CCRT) frequently experience pain, xerostomia, fatigue, sleep disturbance, and other treatment-related toxicities that impair quality of life and treatment adherence, with incomplete relief from current supportive care. This randomized, single-blind, sham-controlled trial evaluates whether foot reflexology (FR), transcutaneous auricular vagus nerve stimulation (ta-VNS), and auricular acupressure (AA) reduce pain, xerostomia, fatigue, sleep disturbance, and treatment-related symptoms in HNC patients receiving cisplatin-based CCRT, compared with usual care. Participants are randomized to a foot reflexology group, an auricular vagus nerve stimulation group (each with true and sham subgroups), or a usual-care control group, and are followed at baseline and weeks 1, 2, and 4.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-13.
Trial Details
NCT Number NCT07711626
Lead Sponsor Tzu Chi University
Collaborators: Hualien Tzu Chi General Hospital
Conditions Head and Neck Neoplasms, Xerostomia, Cancer-related Fatigue, Pain
Enrollment 180 participants
Start Date 2026-07-13
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-24